LO
Lobe Sciences Ltd.
LOBEF · OTC
$0.04 -15.39% (-$0.01)
1M -15.27%
Market Cap $17.2M
P/E Ratio -
Div. Yield -
ROE 338.76%
Bulios Fair Price
$0.06
39.0% upside
Current Price
$0.043
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LOBEF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 9.11x
PEG N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 74.15%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 338.76%
ROA 93.31%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 2.38x
Int. coverage -27.35x
Debt/Equity 0.18x
Stability
29 /100
Unstable EPS volatility 40.66%
Profitable years 0
Beta 0.28x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LOBEF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frederick Dominick Sancilio
Employees
0
Headquarters
Vancouver
Upcoming events
28 DEC
Earnings
Upcoming earnings report